These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3871563)

  • 1. Increased hepatic density and phospholipidosis due to amiodarone.
    Goldman IS; Winkler ML; Raper SE; Barker ME; Keung E; Goldberg HI; Boyer TD
    AJR Am J Roentgenol; 1985 Mar; 144(3):541-6. PubMed ID: 3871563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease.
    Guigui B; Perrot S; Berry JP; Fleury-Feith J; Martin N; Métreau JM; Dhumeaux D; Zafrani ES
    Hepatology; 1988; 8(5):1063-8. PubMed ID: 3417226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.
    Poucell S; Ireton J; Valencia-Mayoral P; Downar E; Larratt L; Patterson J; Blendis L; Phillips MJ
    Gastroenterology; 1984 May; 86(5 Pt 1):926-36. PubMed ID: 6706074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-induced hepatic phospholipidosis: correlation of morphological and biochemical findings in an animal model.
    Pirovino M; Müller O; Zysset T; Honegger U
    Hepatology; 1988; 8(3):591-8. PubMed ID: 3371876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone.
    Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
    Toxicol Lett; 2018 Mar; 284():184-194. PubMed ID: 29248575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
    Lee P; Kirk RG; Reasor MJ
    Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone hepatotoxicity. A clinicopathologic study of five patients.
    Rigas B; Rosenfeld LE; Barwick KW; Enriquez R; Helzberg J; Batsford WP; Josephson ME; Riely CA
    Ann Intern Med; 1986 Mar; 104(3):348-51. PubMed ID: 3946978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance Imaging.
    Lenhard SC; Lev M; Webster LO; Peterson RA; Goulbourne CN; Miller RT; Jucker BM
    Toxicol Pathol; 2016 Jan; 44(1):51-60. PubMed ID: 26516164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone-induced phospholipidosis in rat alveolar macrophages.
    Reasor MJ; Ogle CL; Walker ER; Kacew S
    Am Rev Respir Dis; 1988 Mar; 137(3):510-8. PubMed ID: 2830811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of increased hepatic density during chronic amiodarone therapy].
    Hirakawa K; Abe K; Ayabe Y; Nishimura M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 May; 63(5):221-4. PubMed ID: 12822447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
    Martin WJ; Standing JE
    J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
    van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
    Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of amiodarone-induced phospholipidosis in chimeric mice with a humanized liver.
    Sanoh S; Yamachika Y; Tamura Y; Kotake Y; Yoshizane Y; Ishida Y; Tateno C; Ohta S
    J Toxicol Sci; 2017; 42(5):589-596. PubMed ID: 28904294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased liver density in computed tomography as a result of anti-arrhythmia therapy with amiodarone].
    Heuck A; Mattke S; Seemann M; Müller D; Beuers U; Huber A; Reiser M
    Rofo; 1997 Jan; 166(1):14-7. PubMed ID: 9072097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous pigmentation secondary to amiodarone therapy.
    Trimble JW; Mendelson DS; Fetter BF; Ingram P; Gallagher JJ; Shelburne JD
    Arch Dermatol; 1983 Nov; 119(11):914-8. PubMed ID: 6639112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone.
    Lapinsky SE; Mullen JB; Balter MS
    Can J Cardiol; 1993 May; 9(4):322-4. PubMed ID: 8513425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of hepatic computerized tomographic scanning during amiodarone therapy.
    Markos J; Veronese ME; Nicholson MR; McLean S; Shevland JE
    Am J Cardiol; 1985 Jul; 56(1):89-92. PubMed ID: 4014047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal abdominal computerized tomography with amiodarone therapy and clinical significance.
    Shenasa M; Vaisman U; Wojciechowski M; Denker S; Murthy V; Akhtar M
    Am Heart J; 1984 May; 107(5 Pt 1):929-33. PubMed ID: 6720524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.